Acorah Software Products - Accounts Production 16.4.675 true true false true No description of principal activity 17 November 2023 30 November 2024 30 November 2024 15291736 Dr Kirana Arambage Mr Rangika Wijesinghe iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15291736 2023-11-16 15291736 2024-11-30 15291736 2023-11-17 2024-11-30 15291736 frs-bus:PrivateLimitedCompanyLtd 2023-11-17 2024-11-30 15291736 frs-bus:FilletedAccounts 2023-11-17 2024-11-30 15291736 frs-bus:Micro-entities 2023-11-17 2024-11-30 15291736 frs-bus:EntityHasNeverTraded 2023-11-17 2024-11-30 15291736 frs-bus:AuditExempt-NoAccountantsReport 2023-11-17 2024-11-30 15291736 frs-bus:Director1 2023-11-17 2024-11-30 15291736 frs-bus:Director2 2023-11-17 2024-11-30
Registered number: 15291736
Medoxpro International Limited
Unaudited Financial Statements
For the Period 17 November 2023 to 30 November 2024
Balance Sheet
Registered number: 15291736
30 November 2024
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
Medoxpro International Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15291736 . The registered office is 26 Broadfield Road, Yarnton, Kidlington, OX5 1UL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Kirana Arambage
Director
28/07/2025